ArticleScientific reports2025
Shadowless amyloid imaging with quantitative birefringence contrast.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Amyloid Light Chain Proteins in Cardiovascular Disease: Pathogenesis and Emerging Therapies for Cardiac Amyloidosis.Pharmaceutical research · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
In the diagnosis of amyloidosis using Congo red staining, the apple-green birefringence observed under crossed Nicols has been considered the gold standard for over fifty years. However, a variety of colors, including orange and blue, not just apple-green, are observed in clinical fields. Moreover, the issue of polarization shadows under the crossed Nicols also impedes detailed observations of amyloid deposits, such as senile plaques. The introduction of advanced birefringence microscopes into clinical settings is also limited due to equipment-related challenges. In this study, we propose a simple but robust method that equips a standard optical microscope with polarizers to determine the birefringence and dichroism of Congo red-stained amyloid deposits. By employing an innovative image processing technique that averages multiple images, we achieved a correlation of over 95% with the birefringence distribution. This approach not only minimizes commonly encountered polarization shadows but also enhances the clarity and accuracy of amyloidosis diagnoses. Our strategy simplifies the diagnostic process and facilitates the incorporation of quantitative imaging technologies into routine pathological practices. The findings suggest that characteristic birefringence, independent of azimuthal angle, serves as a reliable marker for amyloidosis, potentially revolutionizing diagnostic protocols in the field.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.